NCT03239496View on ClinicalTrials.gov

A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

PHASE3CompletedINTERVENTIONAL
Enrollment

773

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

November 13, 2018

Study Completion Date

November 13, 2018

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

IPV

Comparison of different vaccination schedules with 2 different vaccines (IPV and f-IPV) and 2 different types of administration (IM and ID)

BIOLOGICAL

f-IPV

Comparison of different vaccination schedules with 2 different vaccines (IPV and f-IPV) and 2 different types of administration (IM and ID)

Trial Locations (4)

Unknown

Hospital Universitario Nuestra Señora de la Alta Gracia, Santo Domingo

Cevaxin Vaccination Center, David

Cevaxin Vaccination Center, La Chorrera

Cevaxin Vaccination Center, Panama City

Sponsors

Lead Sponsor

Fidec Corporation
All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Fidec Corporation

OTHER

NCT03239496 - A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV | Biotech Hunter | Biotech Hunter